Meeting Abstract

Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)


Authors listGhofrani, Hossein-Ardeschir; Grimminger, Friedrich; Hoeper, Marius M.; Kim, Nick H.; Mayer, Eckhard; Simonneau, Gerald; Sikirica, Mirko; Fritsch, Arno; Davie, Neil; Luong, Ba; Wilkins, Martin R.

Publication year2013

JournalEuropean Respiratory Journal

Volume number42

ISSN0903-1936

eISSN1399-3003

PublisherEuropean Respiratory Society



Citation Styles

Harvard Citation styleGhofrani, H., Grimminger, F., Hoeper, M., Kim, N., Mayer, E., Simonneau, G., et al. (2013) Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH), European Respiratory Journal, 42

APA Citation styleGhofrani, H., Grimminger, F., Hoeper, M., Kim, N., Mayer, E., Simonneau, G., Sikirica, M., Fritsch, A., Davie, N., Luong, B., & Wilkins, M. (2013). Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). European Respiratory Journal. 42.



Keywords


Pulmonary hypertensionQuality of lifeTreatments

Last updated on 2025-02-04 at 02:25